Hacker News with Generative AI: Drug Development

Engineered adipocytes implantation suppresses tumor progression in cancer models (nature.com)
Tumors exhibit an increased ability to obtain and metabolize nutrients. Here, we implant engineered adipocytes that outcompete tumors for nutrients and show that they can substantially reduce cancer progression, a technology termed adipose manipulation transplantation (AMT).
A protein folding mystery solved: Study explains core packing fractions (phys.org)
A study published in PRX Life sheds some light on this issue, and could lead to new ways to design proteins for drug therapeutics, novel biomaterials, and other applications.
Progress and prospects of mRNA-based drugs in pre-clinical/clinical applications (nature.com)
In the last decade, messenger ribonucleic acid (mRNA)-based drugs have gained great interest in both immunotherapy and non-immunogenic applications.
Drug Development Failure: how GLP-1 development was abandoned in 1990 (muse.jhu.edu)
What good are whizzy new drugs if the world can't afford them? (economist.com)
How A.I. Is Revolutionizing Drug Development (nytimes.com)
Cost of developing new drugs may be lower than industry claims: trial (theguardian.com)